Hradec Kralovy, Czechia

Lukas Gorecki


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lukas Gorecki: Innovator in Antidote Development

Introduction

Lukas Gorecki is a notable inventor based in Hradec Kralovy, Czech Republic. He has made significant contributions to the field of antidote development, particularly in addressing organophosphate poisoning. His innovative work has led to the creation of a unique patent that showcases his expertise and dedication to improving medical treatments.

Latest Patents

Gorecki holds a patent for "Centrally active and orally bioavailable uncharged bisoxime antidotes for organophosphate poisoning and methods for making and using them." This patent describes uncharged bis-oxime antidotes that are capable of crossing the blood-brain barrier to catalyze the hydrolysis of organophosphate-inhibited human acetylcholinesterase in the central nervous system. The patent also includes various embodiments of devices and methods for administering these antidotes, such as pumps, infusion devices, and syringes.

Career Highlights

Throughout his career, Lukas Gorecki has worked with prestigious institutions, including the University of California and Oak Ridge National Laboratory. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Gorecki has collaborated with notable colleagues such as Zoran Radic and Carlo Ballatore. These partnerships have further enhanced his research and development efforts in the field of antidote innovation.

Conclusion

Lukas Gorecki's contributions to antidote development demonstrate his commitment to advancing medical science. His innovative patent and collaborations with esteemed institutions and colleagues highlight his role as a key figure in this important area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…